Engineering bacterial glycosylation represents a promising strategy to modulate protein function and cellular physiology. In this study, we introduced a heterologous N-glycosyltransferase (AaNGT) into Bacillus subtilis WB800N to explore its impact on the host glycoproteome and functional profile. The recombinant strain successfully expressed and purified AaNGT, which exhibited in vitro activity toward UDP-Gal and UDP-Glc, as confirmed by TLC and HPLC analyses. Comparative glycoproteomic profiling revealed that AaNGT expression substantially increased N-glycosylation events, diversifying glycoprotein targets across metabolic enzymes, stress response proteins, and structural components. Functional annotation indicated enrichment in amino acid metabolism, secondary metabolite biosynthesis, stress and detoxification pathways, and signal transduction processes, suggesting that protein glycosylation remodels host metabolic and regulatory networks. Moreover, engineered glycosylation enhanced adhesion to Caco-2 cells and improved tolerance to simulated gastric and intestinal conditions, highlighting potential benefits for strain stability and survivability. Together, these findings demonstrate that heterologous NGT-mediated glycosylation can reprogram the glycoproteome and functional landscape of B. subtilis, providing a versatile platform for engineering Gram-positive chassis strains with tailored metabolic and physiological traits.
扫码关注我们
求助内容:
应助结果提醒方式:
